• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

凋亡素增强了新城疫病毒的溶瘤特性。

Apoptin enhances the oncolytic properties of Newcastle disease virus.

机构信息

Ministry of Education Key Lab for Avian Preventive Medicine, College of Veterinary Medicine, Yangzhou University, Yangzhou, China.

出版信息

Intervirology. 2012;55(4):276-86. doi: 10.1159/000328325. Epub 2011 Aug 24.

DOI:10.1159/000328325
PMID:21865658
Abstract

OBJECTIVE

Naturally occurring strains of Newcastle disease virus (NDV) have demonstrated the potential to kill cancer cells in both preclinical and clinical studies. Previous studies showed that apoptin, the VP3 protein of chicken infectious anemia virus, is a p53-independent, Bcl-2-insensitive apoptotic protein with the ability to specifically induce apoptosis in transformed cells. In this study, we tested the hypothesis that apoptin enhances NDV-mediated tumor cell death.

METHODS

Reverse genetics was used to engineer an oncolytic NDV strain, FMW, to express apoptin. The antitumor effects of the recombinant virus (rFMW/AP) were also evaluated in the tumor cell lines and tumor-bearing mice.

RESULTS

Compared to the parental strain FMW, rFMW/AP was more potent in killing A459 and SMMC7721 tumor cells. Recombinant NDV also exhibited higher efficacy in suppressing tumor growth in mice bearing A549-induced tumors. Furthermore, rFMW/AP did not display apparent toxic effects in either normal cells or control mice.

CONCLUSION

Our results suggest that the recombinant NDV expressing apoptin is a promising novel antitumor agent.

摘要

目的

天然存在的新城疫病毒(NDV)株在临床前和临床研究中显示出杀死癌细胞的潜力。先前的研究表明,鸡传染性贫血病毒的 VP3 蛋白凋亡素是一种 p53 非依赖性、Bcl-2 不敏感的凋亡蛋白,能够特异性诱导转化细胞凋亡。在这项研究中,我们检验了凋亡素增强 NDV 介导的肿瘤细胞死亡的假设。

方法

采用反向遗传学技术构建表达凋亡素的溶瘤性 NDV 株 FMW。还在肿瘤细胞系和荷瘤小鼠中评估了重组病毒(rFMW/AP)的抗肿瘤作用。

结果

与亲本株 FMW 相比,rFMW/AP 对 A459 和 SMMC7721 肿瘤细胞的杀伤作用更强。重组 NDV 对抑制 A549 诱导的肿瘤小鼠肿瘤生长也表现出更高的疗效。此外,rFMW/AP 对正常细胞或对照小鼠均无明显毒性作用。

结论

我们的结果表明,表达凋亡素的重组 NDV 是一种很有前途的新型抗肿瘤药物。

相似文献

1
Apoptin enhances the oncolytic properties of Newcastle disease virus.凋亡素增强了新城疫病毒的溶瘤特性。
Intervirology. 2012;55(4):276-86. doi: 10.1159/000328325. Epub 2011 Aug 24.
2
Therapeutic efficacy of an hTERT promoter-driven oncolytic adenovirus that expresses apoptin in gastric carcinoma.hTERT 启动子驱动的表达凋亡素的溶瘤腺病毒治疗胃癌的疗效。
Int J Mol Med. 2012 Oct;30(4):747-54. doi: 10.3892/ijmm.2012.1077. Epub 2012 Jul 25.
3
Recombinant oncolytic Newcastle disease virus displays antitumor activities in anaplastic thyroid cancer cells.重组溶瘤新城疫病毒在间变性甲状腺癌细胞中显示抗肿瘤活性。
BMC Cancer. 2018 Jul 18;18(1):746. doi: 10.1186/s12885-018-4522-3.
4
Use of reverse genetics to enhance the oncolytic properties of Newcastle disease virus.利用反向遗传学增强新城疫病毒的溶瘤特性。
Cancer Res. 2007 Sep 1;67(17):8285-92. doi: 10.1158/0008-5472.CAN-07-1025.
5
Potent growth-inhibitory effect of a dual cancer-specific oncolytic adenovirus expressing apoptin on prostate carcinoma.表达凋亡素的双肿瘤特异性溶瘤腺病毒对前列腺癌的强效生长抑制作用。
Int J Oncol. 2013 Mar;42(3):1052-60. doi: 10.3892/ijo.2013.1783. Epub 2013 Jan 21.
6
Analysis of three properties of Newcastle disease virus for fighting cancer: tumor-selective replication, antitumor cytotoxicity, and immunostimulation.新城疫病毒抗癌的三种特性分析:肿瘤选择性复制、抗肿瘤细胞毒性和免疫刺激。
Methods Mol Biol. 2012;797:177-204. doi: 10.1007/978-1-61779-340-0_13.
7
[Progress in using Newcastle disease virus for tumor therapy: a review].[新城疫病毒用于肿瘤治疗的研究进展:综述]
Sheng Wu Gong Cheng Xue Bao. 2010 Aug;26(8):1031-6.
8
[Mechanisms of in vitro anti-tumor effects of a Newcastle disease virus].[新城疫病毒体外抗肿瘤作用机制]
Wei Sheng Wu Xue Bao. 2009 Apr;49(4):512-7.
9
Newcastle disease virus as an oncolytic agent.新城疫病毒作为一种溶瘤剂。
Indian J Med Res. 2009 Nov;130(5):507-13.
10
In vivo efficacy of systemic tumor targeting of a viral RNA vector with oncolytic properties using a bispecific adapter protein.使用双特异性衔接蛋白对具有溶瘤特性的病毒RNA载体进行全身肿瘤靶向的体内疗效。
Int J Oncol. 2006 Dec;29(6):1359-69.

引用本文的文献

1
Delivery of cancer therapies by synthetic and bio-inspired nanovectors.合成和仿生纳米载体递呈癌症治疗药物。
Mol Cancer. 2021 Mar 24;20(1):55. doi: 10.1186/s12943-021-01346-2.
2
Exploring the Prospects of Engineered Newcastle Disease Virus in Modern Vaccinology.探索工程化新城疫病毒在现代疫苗学中的前景。
Viruses. 2020 Apr 16;12(4):451. doi: 10.3390/v12040451.
3
Recent advances of oncolytic virus in cancer therapy.溶瘤病毒在癌症治疗中的最新进展。
Hum Vaccin Immunother. 2020 Oct 2;16(10):2389-2402. doi: 10.1080/21645515.2020.1723363. Epub 2020 Feb 20.
4
Breaking Therapy Resistance: An Update on Oncolytic Newcastle Disease Virus for Improvements of Cancer Therapy.突破治疗耐药性:溶瘤新城疫病毒改善癌症治疗的最新进展
Biomedicines. 2019 Aug 30;7(3):66. doi: 10.3390/biomedicines7030066.
5
Oncolytic Newcastle disease virus induces autophagy-dependent immunogenic cell death in lung cancer cells.溶瘤新城疫病毒诱导肺癌细胞发生自噬依赖性免疫原性细胞死亡。
Am J Cancer Res. 2018 Aug 1;8(8):1514-1527. eCollection 2018.
6
Recombinant oncolytic Newcastle disease virus displays antitumor activities in anaplastic thyroid cancer cells.重组溶瘤新城疫病毒在间变性甲状腺癌细胞中显示抗肿瘤活性。
BMC Cancer. 2018 Jul 18;18(1):746. doi: 10.1186/s12885-018-4522-3.
7
A novel anti-CD22 scFv-apoptin fusion protein induces apoptosis in malignant B-cells.一种新型抗CD22单链抗体可变区-凋亡素融合蛋白可诱导恶性B细胞凋亡。
AMB Express. 2017 Dec;7(1):112. doi: 10.1186/s13568-017-0410-5. Epub 2017 Jun 2.
8
Engineering of double recombinant vaccinia virus with enhanced oncolytic potential for solid tumor virotherapy.具有增强溶瘤潜力的双重组痘苗病毒用于实体瘤病毒疗法的工程构建
Oncotarget. 2016 Nov 8;7(45):74171-74188. doi: 10.18632/oncotarget.12367.
9
The therapeutic effect of death: Newcastle disease virus and its antitumor potential.死亡的治疗作用:新城疫病毒及其抗肿瘤潜力。
Virus Res. 2015 Nov 2;209:56-66. doi: 10.1016/j.virusres.2015.07.001. Epub 2015 Jul 26.
10
Antineoplastic activity of Newcastle disease virus strain D90 in oral squamous cell carcinoma.新城疫病毒D90株在口腔鳞状细胞癌中的抗肿瘤活性
Tumour Biol. 2015 Sep;36(9):7121-31. doi: 10.1007/s13277-015-3433-z. Epub 2015 Apr 16.